Sort
15,842 grants matching “pancreatic cancer”
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$231,701Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION
$231,694Dana-Farber Cancer Institute · R01 · FY2001 · CA
HTS to discover drugs effecting protein folding in the endoplasmic reticulum
$231,500Feroz R Papa · University Of California, San Francisco · R21 · FY2008 · DK
Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents
$231,495Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2024 · CA
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
$231,494Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2024 · CA
Tailoring Therapy to Pancreatic Cancer Subtypes
$231,487Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA
Defining lineage-specific determinants of K-Ras "addiction" in human cancers
$231,443Anurag Singh · Boston University Medical Campus · R00 · FY2014 · CA
Cellular Interactions b/t TGF-B Pathway Members and TERT and c-Myc in Gastro Can
$231,440Bibhuti B Mishra · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA
ONCOGENE SPECIFICITY IN ORGAN-DEFINED CANCERS
$231,405University Of Wisconsin Madison · R01 · FY2000 · CA
PANCREAS CANCER MESOTHELIN ANIMAL MODEL
$231,233Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2009 · CA
Stromal IL-6/Jak-STAT signaling and pancreatitis
$231,000Michael C Ostrowski · Ohio State University · R21 · FY2016 · AI
Establishment of xenopus stem cell lines
$231,000Nadege Gouignard · University Of Wisconsin Milwaukee · R21 · FY2023 · OD
Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancer
$230,971William A Freed-Pastor · Dana-Farber Cancer Inst · K08 · FY2025 · CA
GENETICALLY OPTIMIZED IMMUNOTOXINS FOR LEUKEMIA THERAPY
$230,959University Of Minnesota Twin Cities · R01 · FY2002 · CA
GENETICALLY OPTIMIZED IMMUNOTOXINS FOR LEUKEMIA THERAPY
$230,940University Of Minnesota Twin Cities · R01 · FY2003 · CA
Bioinformatics Core
$230,919Li Ding · Washington University · U54 · FY2023 · CA
Research Project 2
$230,918Kian H Lim · Washington University · U54 · FY2023 · CA
Research Project 1
$230,918Cynthia X Ma · Washington University · U54 · FY2023 · CA
EVALUATE LAG3 AND OTHER IMMUNE MODULATORS
$230,904Drew M. Pardoll · Johns Hopkins University · U19 · FY2009 · CA
Administrative Core
$230,824Alison P Klein · Johns Hopkins University · P50 · FY2020 · CA
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$230,821Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2022 · CA
Regulated Proteolysis in RAS Signal Transduction
$230,764Amy H. Tang · Mayo Clinic Rochester · R01 · FY2007 · GM
Regulated Proteolysis in RAS Signal Transduction
$230,763Amy H. Tang · Mayo Clinic Rochester · R01 · FY2008 · GM
Molecular Mechanisms of Growth Factor Modulated Proliferation
$230,538William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Cancer Biology Training Program
$230,508Jennifer D Black · University Of Nebraska Medical Center · T32 · FY2015 · CA